Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice

@article{Morton2005ActivationAA,
  title={Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice},
  author={C. Morton and Lisa Iacono and Janice L. Hyatt and Kody R. Taylor and Pamela J. Cheshire and Peter James Houghton and Mary K. Danks and Clinton F Stewart and Philip G. Potter},
  journal={Cancer Chemotherapy and Pharmacology},
  year={2005},
  volume={56},
  pages={629-636}
}
Purpose: To examine the antitumor activity and the pharmacokinetics of CPT-11 (irinotecan, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) in a plasma esterase-deficient scid mouse model, bearing human tumor xenografts. Experimental design: Plasma carboxylesterase (CE)-deficient mice were bred with scid animals to develop a strain that would allow growth of human tumor xenografts. Following xenotransplantation, the effect of the plasma esterase on antitumor activity… CONTINUE READING
29 Citations
22 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Metabolism of CPT-11 in esterase deficient mice

  • CL Morton, KR Taylor, +5 authors PM Potter
  • Proc Am Assoc Cancer Res
  • 2002
2 Excerpts

Similar Papers

Loading similar papers…